Cambridge Investment Research Advisors, Inc. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$214
-99.9%
19,956
+1.4%
0.00%0.0%
Q3 2022$184,000
+4.0%
19,675
+1.3%
0.00%0.0%
Q2 2022$177,000
-27.8%
19,419
-3.5%
0.00%0.0%
Q1 2022$245,000
+14.0%
20,132
+14.1%
0.00%0.0%
Q4 2021$215,000
-20.1%
17,650
+1.4%
0.00%0.0%
Q3 2021$269,000
+33.8%
17,399
+23.8%
0.00%0.0%
Q2 2021$201,000
-30.4%
14,057
+5.4%
0.00%
-50.0%
Q1 2021$289,000
+82.9%
13,332
+28.0%
0.00%
+100.0%
Q4 2020$158,000
-8.1%
10,416
+3.4%
0.00%0.0%
Q2 2020$172,000
+26.5%
10,072
-1.9%
0.00%0.0%
Q1 2020$136,000
-31.0%
10,272
-16.1%
0.00%
-50.0%
Q4 2019$197,000
-16.9%
12,244
-5.4%
0.00%0.0%
Q3 2019$237,000
-44.6%
12,938
-34.9%
0.00%
-50.0%
Q2 2019$428,000
-23.3%
19,887
-30.0%
0.00%
-20.0%
Q1 2019$558,000
+50.0%
28,419
-0.6%
0.01%
+25.0%
Q4 2018$372,000
-41.3%
28,589
+8.1%
0.00%
-33.3%
Q3 2018$634,000
+59.3%
26,452
+27.1%
0.01%
+50.0%
Q2 2018$398,000
+57.9%
20,806
+2.2%
0.00%
+33.3%
Q1 2018$252,000
+5.4%
20,356
+4.4%
0.00%0.0%
Q4 2017$239,000
-16.4%
19,496
-6.7%
0.00%
-25.0%
Q3 2017$286,000
-0.7%
20,896
+11.7%
0.00%0.0%
Q2 2017$288,000
+32.7%
18,710
+58.2%
0.00%0.0%
Q1 2017$217,000
+99.1%
11,824
+0.5%
0.00%
+100.0%
Q4 2016$109,000
+26.7%
11,764
+14.3%
0.00%0.0%
Q3 2016$86,00010,2950.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders